ArticleDrug design, development and therapy2026

Safety of Short-T erm Low-Dose Olanzapine in Patients with Cancer and Diabetes Receiving Cisplatin-Based Chemotherapy: A Retrospective TriNetX Cohort Study.

Toshinobu Hayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.